PG

Piyush Garg

Active Director Director DIN 10932953
DIN 10932953 First appointment Feb 2025 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2025
Shareholding value •••• Premium profile

About Piyush Garg

Data last updated:

Piyush Garg is a Director at Dolvis Bio Pharma Private Limited (since 2025). The company operates in Pharma. Dolvis Bio Pharma Private Limited reported revenue of ₹12.57 Cr (FY 2024).

DIN 10932953
Primary Designation Director
Industry Pharma
First Appointment 01 Feb 2025
Oldest Company Age 14 yrs
Largest company Dolvis Bio Pharma Private Limited · ₹12.57 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Dolvis Bio Pharma Private Limited U24232CH2012PTC033674
Director01 Feb 20252012₹12.57 Cr (FY 2024)Active

Board colleagues of Piyush Garg

NameDINCompanyDesignation
Sanjay Kumar Garg02756187Dolvis Bio Pharma Private LimitedDirector

Directorship timeline

Open interactive timeline →
Dolvis Bio Pharma Private Limited
Premium access

Shareholding and investment profile for Piyush Garg

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Piyush Garg

Piyush Garg currently holds 1 directorship: Dolvis Bio Pharma Private Limited (Director, since 01 Feb 2025, revenue ₹12.57 Cr (FY 2024)).

Piyush Garg was first appointed on 01 Feb 2025 as Director at Dolvis Bio Pharma Private Limited.

The current boards of Piyush Garg's companies include Sanjay Kumar Garg (Dolvis Bio Pharma Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available